Daxor Corporation

NASDAQ:DXR

9.13 (USD) • At close November 4, 2024
Bedrijfsnaam Daxor Corporation
Symbool DXR
Munteenheid USD
Prijs 9.133
Beurswaarde 44,173,263
Dividendpercentage 0%
52-weken bereik 7.11 - 10.04
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Michael Richard Feldschuh
Website https://www.daxor.com

An error occurred while fetching data.

Over Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad

Vergelijkbare Aandelen

Vaccinex, Inc. logo

Vaccinex, Inc.

VCNX

3.24 USD

Reneo Pharmaceuticals, Inc. logo

Reneo Pharmaceuticals, Inc.

RPHM

18.2 USD

Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

ALGS

9.48 USD

Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc.

LRMR

7.57 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)